(phosphodiesterase 1C, Calmodulin-Dependent 70kDa (PDE1C))
Featured PDE1C Categories
Recommended PDE1C 抗体
Recommended PDE1C ELISA试剂盒
Recommended PDE1C 蛋白
Latest Publications for our PDE1C Products: "Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome." in: Oncotarget, Vol. 8, Issue 8, pp. 13223-13239, (2017) (PubMed).
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
: "Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling." in: Biochimica et biophysica acta, Vol. 1842, Issue 7, pp. 916-26, (2014) (PubMed).
: "Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1." in: Molecular nutrition & food research, Vol. 55, Issue 11, pp. 1677-89, (2012) (PubMed).
: "Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis." in: Cellular signalling, Vol. 23, Issue 1, pp. 152-60, (2011) (PubMed).
: "cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle." in: American journal of physiology. Endocrinology and metabolism, Vol. 301, Issue 2, pp. E342-50, (2011) (PubMed).
: "Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells." in: American journal of physiology. Regulatory, integrative and comparative physiology, Vol. 297, Issue 5, pp. R1469-76, (2009) (PubMed).
: "Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells." in: Biochemical pharmacology, Vol. 79, Issue 3, pp. 321-9, (2009) (PubMed).
: "Gene expression and protein localization of calmodulin-dependent phosphodiesterase during ontogenesis of chick retina." in: Journal of neuroscience research, Vol. 86, Issue 5, pp. 1017-23, (2008) (PubMed).
: "Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1." in: American journal of physiology. Lung cellular and molecular physiology, Vol. 292, Issue 1, pp. L294-303, (2007) (PubMed).
Synonyms and alternative names related to PDE1CPhosphodiesterase 1c (Pde1c), phosphodiesterase 1C (PDE1C), calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (LOC724389), calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (LOC100019026), phosphodiesterase 1C, calmodulin-dependent b (pde1cb), phosphodiesterase 1C (Pde1c), CG14940, CG14942, CG14943, CG14944, CG31757, CG31758, CG42325, CG44007, Dmel\\CG44007, Dmel_CG14940, Dmel_CG14943, Dmel_CG14944, Dmel_CG31757, Dmel_CG31758, Dmel_CG42325, GB13690, Hcam3, PDE1C, PDE1c
Protein level used designations for PDE1C
- phosphodiesterase 1c
- phosphodiesterase 1C, calmodulin-dependent 70kDa
- calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
- calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C-like
- cam-PDE 1C
- cyclic nucleotide phosphodiesterase 1 C
- phosphodiesterase 1C calmodulin-dependent (70kD)
- Human 3',5' cyclic nucleotide phosphodiesterase (HSPDE1C1A)
- PDCD1, LAG3 (Tebotelimab Biosimilar)
- PDCD1, CTLA4 (Cadonilimab Biosimilar)